Sample sizes of prediction model studies in prostate cancer were rarely justified and often insufficient
(2021)
Journal Article
(2021). Sample sizes of prediction model studies in prostate cancer were rarely justified and often insufficient. Journal of Clinical Epidemiology, 53-60. https://doi.org/10.1016/j.jclinepi.2020.12.011
OBJECTIVE: Developing clinical prediction models (CPMs) on data of sufficient sample size is critical to help minimize overfitting. Using prostate cancer as a clinical exemplar, we aimed to investigate to what extent existing CPMs adhere to recent fo... Read More about Sample sizes of prediction model studies in prostate cancer were rarely justified and often insufficient.